NCT00382226已完成4 期
IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 195
- 试验地点
- 2
- 主要终点
- IOP lowering
研究概览
简要总结
Uncontrolled glaucoma patients being treated with a prostaglandin agent alone or in combination with adjunctive drugs in fixed or unfixed combinations, will be switched from their current therapy to travoprost/timolol fixed combination and either Azopt or placebo
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
IOP lowering
次要结局
- safety
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%GlaucomaOcular HypertensionNCT00440141Allergan40
已完成
4 期
SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)Ocular HypertensionOpen-Angle GlaucomaNCT02419508Alcon Research290
已完成
不适用
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After PhacoemulsificationIntraocular PressureCataractNCT03494257University Hospital of Patras62
已完成
4 期
Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT00761995Alcon Research200
终止
4 期
Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)Intraocular PressureNCT00758342Alcon Research37